medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
泌尿外科指南
检索结果
人体系统
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
良性前列腺增生
前列腺肿瘤
睾丸肿瘤
阴茎癌
泌尿生殖肿瘤
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
6条
与
Oligometastatic
有关的结果
Consensus Statements on PSMA PET/CT Response Assessment Criteria in Prostate Cancer
2021年 发布于
European Journal of Nuclear Medicine and Molecular Imaging
48卷 第2期
所属人体系统：
生殖
|
前列腺肿瘤
无
Monitoring
Oligometastatic
Prostate Cancer
PERCIST
PET/CT
PSMA Ligand
Polymetastatic Prostate Cancer
Prostate Cancer
Prostate-specific Membrane Antigen (PSMA)
RECIST
指南简介
原文链接
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
2020年 发布于
Eur Urol
77卷 第4期
所属人体系统：
生殖
|
前列腺肿瘤
Advanced Prostate Cancer Consensus Conference 2019
Advanced Prostate Cancer
Castration-naïve Prostate Cancer
Castration-resistant Prostate Cancer
Genetics
High-risk Localised Prostate Cancer
Hormone-sensitive Prostate Cancer
Imaging
Oligometastatic
Prostate Cancer
Overall Survival
Progression-free Survival
Prostate Cancer Treatment
Tumour Genomic Profiling
指南简介
原文链接
Consensus Statements on Ablative Radiotherapy for Oligometastatic Prostate Cancer: a Position Paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO)
2019年 发布于
Crit Rev Oncol Hematol
138卷 第_期
所属人体系统：
生殖
|
前列腺肿瘤
Italian Association of Radiotherapy and Clinical Oncology
Ablative Radiotherapy
Oligometastatic
Prostate Cancer
SABR
SBRT
Stereotactic Radiotherapy
指南简介
原文链接
German S3 Guideline for Renal Cell Carcinoma : Presentation and Discussion of Essential Aspects for the Radiation Oncologist
2018年 发布于
Strahlenther Onkol
194卷 第1期
所属人体系统：
泌尿
|
肾癌
无
Purpose: We Aim to Introduce and Discuss the Statements and Recommendations of the German S3 Guideline on Renal Cell Cancer for Daily Practice of Radiation Oncologists
Methods: This Report Comprises Indication
Treatment Decision
Dose Prescription and Current Literature Including Treatment of
Oligometastatic
Disease
Results: According to Different Stages of the Disease and the Structure of the Guideline We Focus on Five Treatment Situations and Recommendations for Decision Making: (1) Neo-/adjuvant Treatment Before Or after Nephrectomy: No Indication for Radiotherapy (2) Small Renal Mass: Stereotactic Ablative Radiotherapy Is Currently Seen as Experimental Option due to Small Patient Numbers Reported in the Literature However
Local Tumor Control Achieved by SBRT Appears Favourable with >90% at 2 Years (3) Oligometastasis: Radiation Treatment with Higher Local Doses Or Stereotactic Treatment Is Possible after Interdisciplinary Discussion Indications for Palliative (4) and Symptomatic Treatment (5) Are Not Different Compared to Other Tumor Entities
Conclusion: Currently
There Is No Evidence-based Indication for Radiation Treatment in the Primary Setting (adjuvant/neoadjuvant Or Definitive) of Renal Cell Cancer in the Future Stereotactic Radiotherapy Should Have a Stronger Role in the Treatment of Medically Inoperable Patients with Primary Renal Cell Cancer and Especially in the Setting of Oligometastasis
指南简介
原文链接
Use of Modern Imaging Methods to Facilitate Trials of Metastasis-directed Therapy for Oligometastatic Disease in Prostate Cancer: a Consensus Recommendation from the EORTC Imaging Group
2018年 发布于
Lancet Oncol
19卷 第10期
所属人体系统：
生殖
|
前列腺肿瘤
EORTC Imaging Group
Oligometastatic
Disease
prostate Cancer
指南简介
原文链接
Management of Patients with Advanced Prostate Cancer: the Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 [Figure Presented]
2018年 发布于
Eur Urol
73卷 第2期
所属人体系统：
生殖
|
前列腺肿瘤
The Advanced Prostate Cancer Consensus Conference (APCCC) 2017
Advanced and High-risk Localized Prostate Cancer
Castration-naive and Castration-resistant Prostate Cancer
Consensus
Oligometastatic
Prostate Cancer
Therapeutics
指南简介
原文链接
